Methylprednisolone Modulates Intracranial Pressure in the Brain Cellular Edema Induced by Water Intoxication
Authors:
- D. MarešováDMD. Marešová
- J. PokornýJPJ. Pokorný
- 29 August 2017
- journal article
- Published by Institute of Physiology of the Czech Academy of Sciences in Physiological Research
- Vol. 66, S511-S516
Abstract
Continuous monitoring of the intracranial pressure (ICP) detects impending intracranial hypertension resulting from the impaired intracranial volume homeostasis, when expanding volume generates pressure increase. In this study, cellular brain edema (CE) was induced in rats by water intoxication (WI). Methylprednisolone (MP) was administered intraperitoneally (i.p.) before the start of CE induction, during the induction and after the induction. ICP was monitored for 60 min within 20 h after the completion of the CE induction by fibreoptic pressure transmitter. In rats with induced CE, ICP was increased (MeanSEM: 14.25±2.12) as well as in rats with MP administration before the start of CE induction (10.55±1.27). In control rats without CE induction (4.62±0.24) as well as in rats with MP applied during CE induction (5.52±1.32) and in rats with MP applied after the end of CE induction (6.23±0.73) ICP was normal. In the last two groups of rats, though the CE was induced, intracranial volume homeostasis was not impaired, intracranial volume as well as ICP were not increased. It is possible to conclude that methylprednisolone significantly influenced intracranial homeostasis and thus also the ICP values in the model of cellular brain edema.Keywords
This publication has 25 references indexed in Scilit:
- Intracranial pressure measured in freely moving rats for days after intracerebral hemorrhageExperimental Neurology, 2014
- Current Status of Neuroprotection Trials for Traumatic Brain Injury: Lessons from Animal Models and Clinical StudiesNeurosurgery, 1999
- Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imagingJournal of Neurosurgery, 1997
- Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury StudyJAMA, 1997
- The Normal and Pathological Physiology of Brain Water1997
- Current concepts of brain edemaJournal of Neurosurgery, 1995
- Pharmacological strategies in CNS traumaTrends in Pharmacological Sciences, 1992
- The neuroprotective pharmacology of methylprednisoloneJournal of Neurosurgery, 1992
- Evaluation of a fiberoptic intracranial pressure monitorJournal of Neurosurgery, 1990
- The outcome from severe head injury with early diagnosis and intensive managementJournal of Neurosurgery, 1977